Glucotrack Announces Successful First Human Clinical Study For Implanted CGM Device
Continuous Blood Glucose Monitor Company Aims To Raise $3m With Public Offering
Glucotrack is a step closer to marketing its implantable continuous blood glucose monitor, which met primary safety endpoints in its first human trial and is pitched as a potential alternative to existing CGM systems.
